Xiaopeng Li

Xiaopeng Li is an Associate Professor in the Genetics & Genome Sciences Program at Michigan State University. His research focuses on the molecular mechanisms underlying pulmonary diseases, including idiopathic pulmonary fibrosis (IPF), cystic fibrosis (CF), and post-viral lung injury. He employs advanced genomic, transcriptomic, and physiological approaches to study airway epithelial function, ion transport, and fibrosis signaling pathways.

Research Interests: Dr. Li's work spans:

• Targeting proton pumps (e.g., ATP12A) and TGF-β signaling for IPF therapy
• CFTR gene correction and airway surface liquid dynamics in CF
• SARS-CoV-2-induced fibrosis and host-viral interactions
• Angiotensin-mediated lung remodeling and epithelial apoptosis

His publications reveal a consistent focus on translational models (porcine/murine systems, human tissue slices) and multi-omics techniques to identify therapeutic targets for respiratory diseases. Recent work emphasizes RNA editing, single-cell mapping of airways, and synergistic antiviral strategies.

Awards: No scientific awards were listed in the provided text.

Academic Activities: While student advising and grant details are unspecified, Dr. Li's extensive publication record and active research (2020–2023) indicate ongoing leadership in pulmonary biology and genetics.